within Pharmacolibrary.Drugs.D_Dermatologicals.D07A_CorticosteroidsPlain.D07AB09_Triamcinolone;

model Triamcinolone
  extends Pharmacolibrary.Drugs.ATC.D.D07AB09;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>D07AB09</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Triamcinolone is a synthetic corticosteroid with anti-inflammatory and immunosuppressive properties. It is used for the treatment of various dermatological disorders, allergic conditions, and, depending on the formulation, for intra-articular and intramuscular administration. Triamcinolone is approved for clinical use and is available in several formulations including topical, injectable, and inhaled forms.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for topical dermatological use in adults, based on general corticosteroid properties due to lack of published primary pharmacokinetic data for topical triamcinolone (ATC D07AB09).</p><h4>References</h4><ol><li><p>Altamirano-Vallejo, JC, et al., &amp; Santos, A (2018). Characterization and Pharmacokinetics of Triamcinolone Acetonide-Loaded Liposomes Topical Formulations for Vitreoretinal Drug Delivery. <i>Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</i> 34(5) 416–425. DOI:<a href=&quot;https://doi.org/10.1089/jop.2017.0099&quot;>10.1089/jop.2017.0099</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29584529/&quot;>https://pubmed.ncbi.nlm.nih.gov/29584529</a></p></li><li><p>Callen, JP (1981). Intralesional corticosteroids. <i>Journal of the American Academy of Dermatology</i> 4(2) 149–151. DOI:<a href=&quot;https://doi.org/10.1016/s0190-9622(81)70017-3&quot;>10.1016/s0190-9622(81)70017-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7217384/&quot;>https://pubmed.ncbi.nlm.nih.gov/7217384</a></p></li><li><p>Szefler, SJ (2001). Pharmacokinetics of intranasal corticosteroids. <i>The Journal of allergy and clinical immunology</i> 108(1 Suppl) S26–S31. DOI:<a href=&quot;https://doi.org/10.1067/mai.2001.115563&quot;>10.1067/mai.2001.115563</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11449203/&quot;>https://pubmed.ncbi.nlm.nih.gov/11449203</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Triamcinolone;
